Evidence map›Paper›PMID 29651972›Full record

ReviewCNS & neurological disorders drug targets2018

N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders.

Michelle Healy-Stoffel, Beth Levant

Open access · greenAbstract readReview
In one paragraph

Review in CNS & neurological disorders drug targets, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology.International journal of molecular sciences · 2020
    Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Gut: The gate and key to brain.Chinese medical journal · 2025
    Review
  12. Article
  13. Review
  14. How gut microbes affect Parkinson's disease: an editorial.Annals of medicine and surgery (2012) · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Gut microbiota, nutrients, and depression.Frontiers in nutrition · 2025
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michelle Healy-StoffelDepartment of Pathology, University of Wisconsin, Madison, WI, United States.
Beth LevantDepartment of Pharmacology, Toxicology, and Therapeutics and the Kansas Intellectual and Developmental Disabilities Research Center, University of Kansas Medical Center, Kansas City, KS, United States.
University of Kansas Medical Center · USUniversity of Wisconsin–Madison · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
UNDERSTANDING THE ROLE OF SMALL RNAS IN ARABIDOPSIS POLLEN DEVELOPMENTP20RR016475 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HUNT, JOAN SHERAR · 2001 to 2011
$38.1M
Research Design and Analysis Core (RDAC)P30HD002528 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI DURHAM, DIANNE NONE · 1985 to 2015
$22.1M
N-3 Fatty Acids: Roles in Parkinson's DiseaseR21NS067422 · NINDS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LEVANT, BETH · 2010 to 2011
$409k
NCRR NIH HHS P20 RR016475NICHD NIH HHS P30 HD002528NIGMS NIH HHS P20 GM103418NINDS NIH HHS R21 NS067422
6 · The paper itself

Abstract

BACKGROUND &

objectiveA number of neuropsychiatric disorders, including Parkinson's disease, schizophrenia, attention deficit hyperactivity disorder, and, to some extent, depression, involve dysregulation of the brain dopamine systems. The etiology of these diseases is multifactorial, involving genetic and environmental factors. Evidence suggests that inadequate levels of n-3 (omega- 3) polyunsaturated fatty acids (PUFA) in the brain may represent a risk factor for these disorders. These fatty acids, which are derived from the diet, are a major component of neuronal membranes and are of particular importance in brain development and function. Low levels of n-3 PUFAs in the brain affect the brain dopamine systems and, when combined with appropriate genetic and other factors, increase the risk of developing these disorders and/or the severity of the disease. This article reviews the neurobiology of n-3 PUFAs and their effects on dopaminergic function.

conclusionClinical studies supporting their role in the etiologies of diseases involving the brain dopamine systems and the potential of n-3 PUFAs in the treatment of these disorders are discussed.

Indexed as

AnimalsBrainDopamineFatty Acids, Omega-3HumansMental DisordersDopamineFatty Acids, Omega-3attention deficit hyperactivity disorderdepressionDopamineomega-3; docosahexaenoic acidParkinson's diseaseschizophrenia.

Identifiers

PMID29651972
PMCPMC6563911
OpenAlexW2797781833

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.